Pacific Clinical Research Network
Pacific Clinical Research Network was a New Zealand-headquartered clinical research organization operating a network of clinical research sites delivering Phase I-IV trial services to pharmaceutical and biotech sponsors. As of September 2025, it merged into Momentum Clinical Research to form Australasia's largest integrated trial network.
- Company typePrivate
- Founded2021
- HeadquartersAuckland, New Zealand
- Headcount51–100
- GTM typeB2B
- OfferingServices
What Pacific Clinical Research Network does
Pacific Clinical Research Network (PCRN) was a New Zealand-based clinical research organization operating a network of clinical research sites delivering Phase I to Phase IV trial execution services to pharmaceutical and biotechnology sponsors. PCRN was headquartered in Auckland and operated across multiple New Zealand regional sites including Waikato, Tauranga, Rotorua, Palmerston North, Hutt Valley, Kapiti, Wellington, Nelson, Christchurch, and Dunedin, with Australian sites in Brisbane, Melbourne, and Sydney. The company was acquired by and merged into Momentum Clinical Research on September 24, 2025, ceasing to operate as a distinct entity and rebranding under the Momentum Clinical Research name. The combined entity now operates as the largest Phase I-IV clinical trial network in Australasia with 19 sites under a centralized management system.
The company's core offering spans full-service clinical trial execution, including accelerated start-up processes with streamlined ethics approval, in-house recruitment driving a continually expanding participant database, and quality and compliance oversight via dedicated quality officers and an internal governance committee. Therapeutic area coverage includes cardiology, dermatology, endocrinology and metabolic disorders, gastroenterology, immunology, respiratory, and rheumatology. Sponsors engage PCRN through a single point of contact with a single budget spanning multiple sites, simplifying multi-center trial management. As of the available data, the network was running 94 active studies.
PCRN's go-to-market was a B2B enterprise sales motion targeting pharmaceutical and biotech sponsors directly, supplemented by public-facing participant recruitment via a corporate website, clinical trial listings, press releases, and participant testimonials. The revenue model is professional services — bespoke CRO contracts priced by trial scope, phase, therapeutic area, duration, and site count rather than standardized list pricing. Following the September 2025 merger into Momentum Clinical Research, PCRN no longer operates as a standalone commercial entity, and the combined Momentum network inherits its capabilities, sites, and sponsor relationships under unified branding.
Pacific Clinical Research Network firmographics
Firmographics- Name
- Pacific Clinical Research Network
- Legal name
- Pacific Clinical Research Network
- Website
- https://pcrn.co.nz
- Company type
- Private
- Founded year
- 2021
- Operating status
- Acquired
- Headcount range
- 51–100 employees
- Short description
- Pacific Clinical Research Network was a New Zealand-headquartered clinical research organization operating a network of clinical research sites delivering Phase I-IV trial services to pharmaceutical and biotech sponsors. As of September 2025, it merged into Momentum Clinical Research to form Australasia's largest integrated trial network.
- Ownership category
- akta.pro rank
Pacific Clinical Research Network industry classification
Industry- Product category
- Clinical Research Services
- NAICS
- Scientific Research and Development Services (5417), Research and Development in the Physical, Engineering, and Life Sciences (54171)
- SIC
- Services-Commercial Physical & Biological Research (8731), Services-Health Services (8000)
- akta.pro primary industry
- Site Network Operators & SMOs (HLAGACAA)
- akta.pro secondary industries
- Clinical Trial Site Operations & Study Coordination (HLAGACAE), Clinical Site Start-Up & Activation (Regulatory/Ethics/Contracts) (HLAGACAC), Clinical Trial Monitoring Support (On-site/Remote) (HLAGACAG), Clinical Development (Phase I–III Trial Design & Execution) (HLAIALAE)
Keywords
Where Pacific Clinical Research Network is headquartered
LocationHeadquarters
- HQ city
- Auckland
- HQ country
- New Zealand
- HQ region
- Oceania
Offices15 records
Markets served
Pacific Clinical Research Network business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales, Others
Revenue model
- Clinical Research Services: Contract research organization (CRO) services providing Phase I to IV clinical trial execution for pharmaceutical and biotech sponsors. Revenue generated through service contracts for trial conduct, participant recruitment, site management, and regulatory compliance support. Services provided across a network of 19 integrated research sites.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels4 records
Pacific Clinical Research Network product offering
Product offeringCore offering
Pacific Clinical Research Network operates an integrated network of 19 clinical research sites across Australia and New Zealand, providing Phase I to IV clinical trial execution services for pharmaceutical and biotech sponsors. Services span trial start-up, ethics approval, participant recruitment, site management, regulatory compliance, and quality assurance under a single centralized system. The network offers a central point of contact and single budget across multiple sites for streamlined multi-center trial delivery.
Product overview
Momentum Clinical Research (formerly Pacific Clinical Research Network) operates as a unified clinical trial platform offering comprehensive Phase I-IV research services across 19 streamlined sites in Australia and New Zealand. The portfolio includes core clinical trial execution services, accelerated start-up capabilities, inhouse recruitment drives, quality and compliance oversight, and streamlined multi-site coordination. Services are organized by therapeutic areas including cardiology, dermatology, endocrinology/metabolic disorders, gastroenterology, immunology, respiratory, and rheumatology. The network is powered by centralized processes, quality officers, and internal governance to deliver consistent trial execution across all locations.
Differentiator
Problem solved
Functional benefit
Products and services
- Phase I-IV Clinical Trial Services Full phase clinical research services spanning Phase I to Phase IV trials across most therapeutic areas, conducted through a network of 19 clinical research sites in Australia and New Zealand for pharmaceutical and biotech sponsors.
Quantifiable outcome
- 94 active studies currently being conducted across the network
Companies that use Pacific Clinical Research Network
Customer profileSegments3 records
Ideal customer profiles1 record
Pacific Clinical Research Network technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
Pacific Clinical Research Network partnerships and signals
Strategic signalScale indicators6 records
Recent moves6 records
Expansion highlights5 records
Pacific Clinical Research Network competitors and assessment
Company assessmentBroad incumbents
- IQVIA: Global clinical research and site-network operator serving pharma sponsors worldwide; overlaps on trial execution and site management as a broad incumbent.
- ICON plc: Global CRO offering full clinical development services including site management; a much larger incumbent that competes for the same pharma/biotech trial spend.
- Novotech: Asia-Pacific headquartered CRO managing clinical trials for biotech sponsors across the region, a larger incumbent overlapping PCRN's sponsor customers and Australasian geography.
Regional players
- Avance Clinical: Australian CRO supporting biotech sponsors running trials in Australasia; overlaps on sponsor base and geography though it is a full-service CRO rather than a site network.
- Scientia Clinical Research: Sydney-based clinical trial site running early-phase and specialty trials, competing in the same Australasian site-operations space.
- Linear Clinical Research: Perth-based Phase I/early-phase clinical trial site serving global sponsors, comparable regional site operator in Australia.
Direct peers
- Velocity Clinical Research: A large integrated clinical trial site network (SMO) running multi-therapeutic trials for pharma/biotech sponsors, mirroring PCRN's owned-site network model but at global scale.
- Emeritus Research: Australian dedicated clinical research site network conducting Phase I-IV trials across multiple therapeutic areas, closely comparable to PCRN's site-network model.
- CMAX Clinical Research: Australian clinical trial site conducting early- and late-phase studies for sponsors, a direct regional competitor in the same Australasian trial market.
- Nucleus Network: Australia-based clinical trial site operator specializing in Phase I trials across Australasia and the US, directly overlapping PCRN's regional site-operations focus.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat5 records
Key risks5 records
Key highlights6 records
Customer concentration
Pacific Clinical Research Network financial estimates
Financial estimateRevenue estimate
Valuation estimate
Pacific Clinical Research Network leadership team
Management profileNumber of profiles
Profiles3 records
Pacific Clinical Research Network funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Pacific Clinical Research Network M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Pacific Clinical Research Network
What does Pacific Clinical Research Network do?
Pacific Clinical Research Network operates an integrated network of 19 clinical research sites across Australia and New Zealand, providing Phase I to IV clinical trial execution services for pharmaceutical and biotech sponsors. Services span trial start-up, ethics approval, participant recruitment, site management, regulatory compliance, and quality assurance under a single centralized system. The network offers a central point of contact and single budget across multiple sites for streamlined multi-center trial delivery.
Is Pacific Clinical Research Network a public or private company?
Pacific Clinical Research Network is a private company. It is classified as corporate owned and is currently acquired.
When was Pacific Clinical Research Network founded?
Pacific Clinical Research Network was founded in 2021. It employs 51 to 100 people.
Where is Pacific Clinical Research Network based?
Pacific Clinical Research Network is headquartered in Auckland, New Zealand, in the Oceania region.
How does Pacific Clinical Research Network make money?
One revenue line is on record: clinical Research Services.
Who are Pacific Clinical Research Network's main competitors?
Broad incumbents on record are IQVIA, ICON plc and Novotech. Regional players are Avance Clinical, Scientia Clinical Research and Linear Clinical Research. Direct peers are Velocity Clinical Research, Emeritus Research, CMAX Clinical Research and Nucleus Network.
Does Pacific Clinical Research Network have an API?
No public API is recorded for Pacific Clinical Research Network.
What industry is Pacific Clinical Research Network in?
Pacific Clinical Research Network's product category is Clinical Research Services. Its primary akta.pro industry code is HLAGACAA, Site Network Operators & SMOs, with a secondary code of HLAGACAE, Clinical Trial Site Operations & Study Coordination. Its NAICS code is 5417 and its SIC code is 8731.